Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
17,3 SEK | +3,72% | +6,00% | +22,00% |
Omzet 2024 * | 104 mln. 9,51 mln. 8,89 mln. | Omzet 2025 * | 393 mln. 35,94 mln. 33,61 mln. | Marktkapitalisatie | 1,93 mld. 177 mln. 165 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -151 mln. -13,8 mln. -12,91 mln. | Nettowinst (verlies) 2025 * | -166 mln. -15,17 mln. -14,19 mln. | EV/omzet 2024 * | 16 x |
Nettoliquiditeiten 2024 * | 274 mln. 25,02 mln. 23,4 mln. | Nettoliquiditeiten 2025 * | 222 mln. 20,28 mln. 18,97 mln. | EV/omzet 2025 * | 4,35 x |
K/w-verhouding 2024 * |
-12,8
x | K/w-verhouding 2025 * |
-7,74
x | Werknemers | 24 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 86,02% |
Recentste transcriptie over Vicore Pharma Holding AB
1 dag | +3,72% | ||
1 week | +6,00% | ||
Lopende maand | +17,85% | ||
1 maand | +18,01% | ||
3 maanden | +28,34% | ||
6 maanden | +22,87% | ||
Lopend jaar | +22,00% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ahmed Mousa
CEO | Chief Executive Officer | 40 | 09-09-23 |
Hans Jeppsson
DFI | Director of Finance/CFO | - | 01-01-17 |
Elin Rosendahl
CTO | Chief Tech/Sci/R&D Officer | - | 16-11-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chairman | 57 | 01-01-18 | |
Director/Board Member | 66 | 01-01-18 | |
Michael Buschle
BRD | Director/Board Member | 64 | 01-01-23 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 17,3 | +3,72% | 92 932 |
25-04-24 | 16,68 | -2,91% | 149 676 |
24-04-24 | 17,18 | -1,49% | 96 148 |
23-04-24 | 17,44 | +2,95% | 160 468 |
22-04-24 | 16,94 | +3,80% | 107 729 |
uitgestelde koers Nasdaq Stockholm, 26 april 2024 om 17:29 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+22,00% | 176 mln. | |
-2,31% | 103 mld. | |
+0,56% | 95,28 mld. | |
+1,69% | 22,15 mld. | |
-17,37% | 21,02 mld. | |
-9,30% | 18,15 mld. | |
-41,01% | 16,74 mld. | |
-14,85% | 16,05 mld. | |
+3,21% | 13,68 mld. | |
+33,54% | 12,17 mld. |